Cigarette Smoke Exposure Animal Models Of COPD: Procedural Variations And Apparatus.pdf

This article reviews the various animal models used to study chronic obstructive pulmonary disease (COPD), a progressive lung disorder primarily caused by cigarette smoking. The authors emphasize the importance of well-designed and validated models for COPD research, as current treatments have limited effectiveness.

Key Points:

COPD Pathophysiology:
The article outlines the complex pathophysiology of COPD, involving inflammation, mucus hypersecretion, airway remodeling, emphysema, and imbalances in proteases and antioxidants.

Animal Models for COPD:
Different models are discussed, categorized by induction methods:
Cigarette Smoke (CS) Exposure: The most common method, using research-grade cigarettes to deliver controlled concentrations of total suspended particles (TSP) or total particulate matter (TPM), including nicotine and carbon monoxide.
Lipopolysaccharide (LPS) Instillation: Induces inflammation and chronic bronchitis through activation of TLR-4 and p38 MAPK signaling pathways.
Respiratory Infections (RI): Aggravates COPD symptoms by combining respiratory pathogens with CS or LPS exposure.
Genetic Modifications: Models involving specific gene alterations, like AAT deficiency, to study genetic contributions to COPD.

Animal Species Preferences:
The article notes that mouse models are widely used due to their accessibility and ease of manipulation, while rat and guinea pig models offer anatomical similarities to humans, making them valuable for specific studies.

Apparatus Considerations:
Emphasizes the need for suitable apparatus designed for optimal exposure, reliability, and sturdiness to minimize harm to experimenters during COPD induction in murine models.

* Conclusion:
The authors conclude that both appropriate animal models and validated apparatus are crucial for successful COPD research, ultimately leading to more effective treatments for this growing global health concern.